Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract

Age

Volumn 33, Issue 3, 2011, Pages 377-384

  Hashim, Zehra ^a   Zarina, Shamshad ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

AGEs; Cataract; CEL; Diabetes; Non enzymatic glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA CRYSTALLIN; GLUCOSE; LYSINE DERIVATIVE; N CARBOXYETHYL LYSINE; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ADULT; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; TISSUE LEVEL; UPREGULATION; WESTERN BLOTTING;

AGED; BETA-CRYSTALLINS; CATARACT; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; LYSINE; MALE; MIDDLE AGED;

EID: 80655141511     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-010-9177-1     Document Type: Article

References (35)

1. Ahmed N, Furth AJ (1991) A microassay for protein glycation based on the periodate method. Anal Biochem 192:109-111. doi:10.1016/0003-2697(91)90193-W
2. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N-(carboxyethyl) lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-570
3. Brian G, Taylor H (2001) Cataract blindness: challenges for the 21st century. Bull WHO 79:249-256. doi:10.1590/S0042-96862001000300015
4. Duhaiman AS (1995) Glycation of human lens proteins from diabetic and (nondiabetic) senile cataract patients. Glyco-conj J 12:618-621. doi:10.1007/BF00731255
5. Dunn JA, Patrick JS, Thorpe SR, Baynes JW (1989) Oxidation of glycated proteins: age-dependent accumulation of N-(carboxymethyl) lysine in lens proteins. Biochemistry 28:9464-9468. doi:10.1021/bi00450a033 (Pubitemid 20000724)
6. Franke S, Dawczynski J, Strobel J, Niwa T, Stahl P, Stein G (2003) Increased levels of advanced glycation end products in human cataractous lenses. J Cataract Refract Surg 29:998-1004. doi:10.1016/S0886-3350(02)01841-2 (Pubitemid 36622675)
7. Groenen PJ, Merck KB, de Jong WW, Bloemendal H (1994) Structure and modifications of the junior chaperone alpha-crystallin. From lens transparency to molecular pathology. Eur J Biochem 225:1-19. doi:10.1111/ j.1432-1033.1994.00001.x
8. Gul A, Rahman MA, Salim A, Simjee SU (2009) Advanced glycation end products in senile diabetic and nondiabetic patients with cataract. J Diab Comp 23:343-348. doi:10.1016/j.jdiacomp.2008.04.001
9. Harding JJ (1981) Changes in lens proteins in cataract. In: Bloemendal H (ed) Molecular and cellular biology of the eye lens. Wiley, New York, pp 327-365
10. Harding JJ (2002) Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev 1:465-479. doi:10.1016/ S1568-1637(02)00012-0 (Pubitemid 38340335)
11. Hashim Z, Ilyas A, Saleem A, Salim A, Zarina S (2009) Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Rad Biol Med 46:1089-1095. doi:10.1016/j.freeradbiomed.2009.01.012
12. Hashimoto H, Arai K, Yoshida S, Chikuda M, Obara Y (1997) Pentosidine and autofluorescence in lenses of diabetic patients. Jpn J Ophthalmol 41:274-277. doi:10.1016/ S0021-5155(97)00056-7 (Pubitemid 27474577)
13. Ivancic D, Mandic Z, Barac J, Kopic M (2005) Cataract surgery and post operative complication in diabetic patients. Coll Antropol 29:55-58. doi:10.1016/collantropol.2005 (Pubitemid 41265100)
14. Jadoon Z, Shah SP, Bourne R, Dineen B, Khan MA, Gilbert CE, Foster A, Khan MD (2007) Cataract prevalence, cataract surgical coverage and barriers to uptake of cataract surgical services in Pakistan: the Pakistan national blindness and visual impairment survey. Br J Ophthalmol 91:1269-1273. doi:10.1136/bjo.2006.106914 (Pubitemid 47492851)
15. Kokiwar PR, Gupta S, Durge PM (2007) Prevalence ofdiabetes in a rural area ofcentral India. Int J Diab Dev Ctries 27:8-10. doi:10.4103/0973-3930.34750
16. Kumar PA, Kumar MS, Reddy GB (2007) Effect of glycation on rat alpha-crystallin structure and chaperone-like func-tion. Biochem J 408:251-258. doi:10.1042/BJ20070989 (Pubitemid 350206348)
17. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685. doi:10.1038/227680a0
18. Monnier VM, Cerami A (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211:491-493. doi:10.1126/science.6779377 (Pubitemid 11145319)
19. Monnier VM, Stevens VJ, Cerami A (1979) Nonenzymatic glycosylation, sulfhydryl oxidation and aggregation of lens proteins in experimental sugar cataracts. J Exp Med 150:1098-1107. doi:10.1084/jem.150.5.1098 (Pubitemid 10099402)
20. Nagaraj RH, Monnier VM (1992) Isolation and characterization of a blue fluorophore from human eye lens crystallins: in vitro formation from Maillard reaction with ascorbate and ribose. Biochim Biophys Acta 1116:34-42. doi:10.1016/ 0304-4165(92)90125-E
21. Nagaraj RH, Sady C (1996) The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett 382:234-238. doi:10.1016/0014- 5793(96)00142-1 (Pubitemid 26092198)
22. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM (1991) High correlation between pentosidine protein cross-links and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA 88:10257-10261. doi:10.1073/pnas.88.22.10257 (Pubitemid 21915814)
23. Namiki M, Oka M, Otsuka M, Miyazawa T, Fujimoto K, Namiki K (1993) Weak Chemiluminescence at an early stage of Maillard reaction. J Agric Food Chem 41:1704-1709. doi:10.1021/jf00034a035
24. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685. doi:10.1056/ NEJM199306103282306 (Pubitemid 23157351)
25. Peppa M, Uribarri J, Vlassara H (2003) Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clin Diab 21:186-187. doi: 10.2337/diaclin.21.4.186
26. Peppa M, Uribarri J, Vlassara H (2004) The role of advanced glycation end products in the development of atheroscle-rosis. Curr Diabetes Rep 4:31-36. doi:10.1007/s11892-004-0008-6 (Pubitemid 39359508)
27. Pokupec R, Kalauz M, Turk N, Turk Z (2003) Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses. Graefe Arch Clin Exp Ophthalmol 241:378-384. doi:10.1007/s00417-002-0616-2 (Pubitemid 36748573)
28. Pollreisz A, Schmidt-Erfurth U (2010) Diabetic cataract pathogenesis, epidemiology and treatment. J Ophthalmol. doi:10.1155/2010/608751
29. Rathur HM, Boulton AJ (2007) The diabetic foot. Clin Dermatol 25:109-120. doi:10.1016/j.clindermatol.2006.09.015 (Pubitemid 46177468)
30. Reed NA, Oh D-J, Czymmek KJ, Duncan MK (2001) An immunohistochemical method for the detection of proteins in the vertebrate lens. J Immunol Methods 253:243-252. doi:10.1016/S0022-1759(01)00374-X (Pubitemid 32522531)
31. Stitt AW (2005) The Maillard reaction in eye diseases. Ann NY Acad Sci 1043:582-597. doi:10.1196/annals.1338.066 (Pubitemid 41123948)
32. Swamy MS, Abraham EC (1991) Differential glycation of rat alpha, beta and gamma crystallins. Exp Eye Res 52:439-444. doi:10.1016/0014-4835(91)90040-L
33. Vinson JA (2006) Oxidative stress in cataracts. Pathophysiology 13:151-162. doi:10.1016/j.pathophys.2006.05.006 (Pubitemid 44026670)
34. Yamagishi S, Matsui T, Ueda S, Nakamura K, Imaizumi T (2007) Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. Cardiovasc Hematol Agents Med Chem 5:236-240. doi:10.2174/ 187152507781058681 (Pubitemid 47180854)
35. Zarina S, Zhao HR, Abraham EC (2000) Advanced glycation end products in human senile and diabetic cataractous lenses. Mol Cell Biochem 210:29-34. doi:10.1023/ A:1007015416572 (Pubitemid 30629066)